Max Neeman International Release: CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
10/17/2011 12:52:39 PM
More...
|
Max Neeman International ISO 14155: 2011 Certified for Medical Device Trials
9/28/2011 11:30:04 AM
More...
|
Max Neeman International Responds to New India Clinical Research Guidelines
5/4/2011 7:21:36 AM
More...
|
Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study
4/12/2011 9:20:52 AM
More...
|
Max Neeman International Develops Innovative Approach for Rare Disease Studies; Hires Team of Experts
3/1/2011 11:05:06 AM
More...
|
Over 200 Studies Awarded to India-Based CRO Max Neeman International
1/26/2011 9:14:22 AM
More...
|
Chief Operating Officer of Leading India-based CRO, Max Neeman International Featured as One of India's 'Top 10 Women Achievers in Life Sciences Industry'
12/2/2010 7:15:28 AM
More...
|
Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
10/1/2010 8:23:34 AM
More...
|
Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
6/30/2010 9:38:09 AM
More...
|
Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites
5/12/2010 10:52:59 AM
More...
|
|